Publication

Approach to pancreas transplant during the COVID-19 pandemic

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Kenneth J. Woodside, University of MichiganNeeraj Singh, John C. McDonald Regional Transplant CenterKrista L. Lentine, St Louis UniversityMartha Pavlakis, Beth Israel Deaconess Medical CenterArpita Basu, Emory UniversityFranco H. Cabeza Rivera, University of MississippiClark D. Kensinger, Piedmont Transplant InstituteSandesh Parajuli, University of WisconsinSamuel Sultan, Weill Cornell Medical CollegeEkamol Tantisattamo, University of California IrvineRonald Parsons, Emory UniversityMatthew Cooper, Medstar Georgetown Transplant Institute
Language
  • English
Date
  • 2020-12-20
Publisher
  • WILEY
Publication Version
Copyright Statement
  • © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 35
Issue
  • 2
Start Page
  • e14177
End Page
  • e14177
Abstract
  • The COVID‐19 pandemic has disrupted many aspects of vital medical care, including transplantation—with another surge in progress. In March 2020, faced with potential shortages of ventilators, dialysis machines, and personal protective equipment, hospital systems drastically scaled back or halted vital activities—including new transplants—in effort to mobilize resources for anticipated or realized COVID‐19 admissions. As for all solid organ transplant, 1 , 2 pancreas transplant has been impacted by the pandemic, but has received less attention. As of October 26, 2020, only 781 total pancreas transplants had been performed in the United States, 2 which is a drop of ~10% from the corresponding date last year (Figure 1A). Based on historical volume, we would have projected 1038 total pancreas transplants in the United States during 2020, including simultaneous pancreas‐kidney transplant (SPKT), pancreas after kidney transplant (PAKT), and pancreas transplant alone (PTA). While pancreas transplant activity has increased since June 2020, we estimate the actual number of pancreas transplants may reach about 900. Based on SRTR data (Figure 1B), pancreas transplant volume changes did not seem to be related to historic pancreas transplant center volume, 3 suggesting that local pandemic conditions may be the dominant factor.
Author Notes
  • Ronald F. Parsons, Division of Transplantation, Department of Surgery, Emory University School of Medicine, Atlanta, GA 30322, USA. ronald.parsons@emory.edu
Keywords
Research Categories
  • Biology, Virology
  • Health Sciences, Medicine and Surgery
  • Health Sciences, Health Care Management

Tools

Relations

In Collection:

Items